SGP

SpyGlass Pharma, Inc.

NASDAQ: SGP · HEALTHCARE · BIOTECHNOLOGY

$21.91

+1.34% today

Updated 2026-07-29

Market cap

$685.05M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.31

Dividend yield

—

52W range

$17 – $32

Volume

0.1M

Market cap

$685.05M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.31

Dividend yield

—

52W range

$17 – $32

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-1.4

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$45.00

+105.39%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -1.36 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-14.22M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00
Net income	$-13.32M	$-29.16M	$-39.87M	$-13.82M
EPS	—	—	—	$-1.31
Free cash flow	$-12.49M	$-24.02M	$-33.49M	$-14.22M
Profit margin	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SGP	$685.05M	28	4.3	3.0	5.0	6.5	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

SpyGlass Pharma, Inc. trades at $21.91. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -1.36, it sits in the distress.

Frequently asked questions

What is SpyGlass Pharma, Inc.'s stock price?

SpyGlass Pharma, Inc. (SGP) trades at $21.91.

Is SpyGlass Pharma, Inc. overvalued?

SpyGlass Pharma, Inc. carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of SpyGlass Pharma, Inc. (SGP)?

The 12-month analyst consensus target is $45.00, about 105.4% above the current $21.91. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

SpyGlass Pharma, Inc.'s Altman Z-Score is -1.36, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-17.43%

Beta—

50D MA$20.07

200D MA$23.14

Shares out0.03B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week+5.26%

1 month-0.14%

3 months-2.30%

YTD—

1 year—

3 years—

5 years—

Compare

SGP vs LLY →SGP vs JNJ →SGP vs ABBV →Stock screener →